Horizon says cell service purchase will drive upstream and downstream
Horizon, which supplies genomics research services, has bought cell-screening business CombinatoRx from Zalicus for £4.74m ($8m) and plans more acquisitions.
Archives for May 20, 2014
Biopharm launches modelling tool to slash process development costs
Biologics makers must think about costs surrounding chronic therapies and continuous processing, says a company making software predicting manufacturing scenarios.
Q&A on FDA’s draft biosimilar guidance: New expectations?
BioPharma-Reporter.com recently spoke with contract testing supplier BioOutsource to see what its take is on biosimilars now that the FDA’s draft guidance on biosimilarity has been released. The following is a lightly edited interview with BioOutsource’s...